Patent ID: 11894141
Assignee: PROGENICS PHARMACEUTICALS, INC.
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 30:
31. A system for tracking prostate cancer progression and treatment efficacy over time, for one or more patient(s), the system comprising:
a processor; and
a memory having instructions stored thereon, wherein the instructions, when executed by the processor, cause the processor to:
(a) repeatedly receive and store in a database, over time, a plurality of medical images for each of the one or more patient(s) to obtain, for each of the one or more patient(s), a series of medical images taken over time;
(b) for each of the one or more patient(s), automatically analyze the series of medical images for the patient, using a machine learning algorithm, to determine values of one or more risk indices for each medical image of the series, thereby tracking determined values of the one or more risk indices over a course prostate cancer progression and treatment for the patient; and
(c) for each of the one or more patient(s), store the determined values of the one or more risk indices, each indicative of prostate cancer state or progression, for the patient for further processing and/or cause display of a graphical representation of the determined values of the one or more risk indices for the patient
wherein the series of medical images for a particular patient of the one or more patient(s) comprises a CT scan overlaid with a nuclear medicine image acquired at a substantially same time as the CT scan and following administration to the patient of an imaging agent comprising a Prostate Specific Membrane Antigen (PSMA) binding agent comprising a radionuclide, and wherein step (b) comprises:
using the composite image to geographically identify a 3D boundary for each of one or more regions of imaged tissue within the nuclear medicine image; and
computing the value of each of the one or more risk indices using the nuclear medicine image with the identified 3D boundary(ies) of the one or more region(s), and
wherein the system is a cloud-based system.